Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions

Background Oral cancer survival rates increase significantly when it is detected and treated early. Unfortunately, clinicians now lack tests which easily and reliably distinguish pre-malignant oral lesions from those already transitioned to malignancy. A test for proteins, ones found in non-invasively-collected whole saliva and whose abundances distinguish these lesion types, would meet this critical need. Methodology/Principal Findings To discover such proteins, in a first-of-its-kind study we used advanced mass spectrometry-based quantitative proteomics analysis of the pooled soluble fraction of whole saliva from four subjects with pre-malignant lesions and four with malignant lesions. We prioritized candidate biomarkers via bioinformatics and validated selected proteins by western blotting. Bioinformatic analysis of differentially abundant proteins and initial western blotting revealed increased abundance of myosin and actin in patients with malignant lesions. We validated those results by additional western blotting of individual whole saliva samples from twelve other subjects with pre-malignant oral lesions and twelve with malignant oral lesions. Sensitivity/specificity values for distinguishing between different lesion types were 100%/75% (p = 0.002) for actin, and 67%/83% (p<0.00001) for myosin in soluble saliva. Exfoliated epithelial cells from subjects' saliva also showed increased myosin and actin abundance in those with malignant lesions, linking our observations in soluble saliva to abundance differences between pre-malignant and malignant cells. Conclusions/Significance Salivary actin and myosin abundances distinguish oral lesion types with sensitivity and specificity rivaling other non-invasive oral cancer tests. Our findings provide a promising starting point for the development of non-invasive and inexpensive salivary tests to reliably detect oral cancer early.

[1]  S. Muthuswamy,et al.  Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis. , 2009, Current opinion in cell biology.

[2]  C. Hsiung,et al.  G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization. , 2009, Cancer research.

[3]  P. Friedl,et al.  Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.

[4]  Erik Sahai,et al.  The actin cytoskeleton in cancer cell motility , 2009, Clinical & Experimental Metastasis.

[5]  J. Gurenlian.  Inflammation: the relationship between oral health and systemic disease. , 2009, Dental assistant.

[6]  Xiao-jun Zhou,et al.  Expression of CD34, α-Smooth Muscle Actin and Transforming Growth Factor-β1 in Squamous Intraepithelial Lesions and Squamous Cell Carcinoma of the Cervix , 2009 .

[7]  Alan Hall,et al.  The cytoskeleton and cancer , 2009, Cancer and Metastasis Reviews.

[8]  David Elashoff,et al.  Salivary Proteomics for Oral Cancer Biomarker Discovery , 2008, Clinical Cancer Research.

[9]  J. Garlick,et al.  E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents. , 2008, The Journal of investigative dermatology.

[10]  Qianming Chen,et al.  Comparative Proteomics Approach to Screening of Potential Diagnostic and Therapeutic Targets for Oral Squamous Cell Carcinoma*S , 2008, Molecular & Cellular Proteomics.

[11]  Sudhir Bahadur,et al.  Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry*S , 2008, Molecular & Cellular Proteomics.

[12]  Victor G Prieto,et al.  Metastatic basal cell carcinoma exhibits reduced actin expression , 2008, Modern Pathology.

[13]  J. Carlis,et al.  Proteomics Analysis of Cells in Whole Saliva from Oral Cancer Patients via Value-added Three-dimensional Peptide Fractionation and Tandem Mass Spectrometry*S , 2008, Molecular & Cellular Proteomics.

[14]  Timothy J Griffin,et al.  iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer. , 2007, Journal of proteome research.

[15]  Zhi-Yuan Zhang,et al.  Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[16]  F. Tsai,et al.  Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[17]  Chap T Le,et al.  A solution for the most basic optimization problem associated with an ROC curve , 2006, Statistical methods in medical research.

[18]  J. Hu,et al.  Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. , 2006, Archives of oral biology.

[19]  D. Wong.  Towards a simple, saliva-based test for the detection of oral cancer. , 2006, Expert review of molecular diagnostics.

[20]  K. Krapfenbauer,et al.  Identification of differentially expressed, tumor‐associated proteins in oral squamous cell carcinoma by proteomic analysis , 2006, Electrophoresis.

[21]  Shan-zhen Sun,et al.  Expression of stromal CD34 and α-smooth muscle actin in oral invasive cancer , 2006 .

[22]  Timothy J Griffin,et al.  A Catalogue of Human Saliva Proteins Identified by Free Flow Electrophoresis-based Peptide Separation and Tandem Mass Spectrometry*S , 2005, Molecular & Cellular Proteomics.

[23]  S. Ram,et al.  Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. , 2005, International journal of oral and maxillofacial surgery.

[24]  Qing‐Yu He,et al.  Comparative proteomic analysis of esophageal squamous cell carcinoma , 2005, Proteomics.

[25]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[26]  N. Rhodus.  New initiatives in the diagnosis and prevention of oral cancer. , 2004, Northwest dentistry.

[27]  R. Griffin,et al.  Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: a preliminary study. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[28]  L. Hofman,et al.  Human saliva as a diagnostic specimen. , 2001, The Journal of nutrition.

[29]  J. McDevitt,et al.  Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care. , 2010, Nanomedicine.

[30]  Q. Li,et al.  Expression of CD34, alpha-smooth muscle actin and transforming growth factor-beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the cervix. , 2009, The Journal of international medical research.

[31]  S. Ghanny,et al.  iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. , 2009, Journal of proteome research.

[32]  P. Speight,et al.  Critical Evaluation of Diagnostic Aids for the Detection of Oral Cancer , 2008 .

[33]  T. V. Van Dyke.  The management of inflammation in periodontal disease. , 2008, Journal of periodontology.

[34]  Shan-zhen Sun,et al.  [Expression of stromal CD34 and alpha-smooth muscle actin in oral invasive cancer]. , 2006, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

[35]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[36]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .

[37]  Craig S. Miller,et al.  NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. , 2005, Cancer detection and prevention.

[38]  N. Rhodus.  Oral cancer: leukoplakia and squamous cell carcinoma. , 2005, Dental clinics of North America.

[39]  Craig S. Miller,et al.  NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma , 2005 .

[40]  Joshua E. Elias,et al.  Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. , 2003, Journal of proteome research.

[41]  K. Warnakulasuriya,et al.  Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. , 1991, Cancer detection and prevention.

[42]  Warnakulasuriya Ka,et al.  Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. , 1991 .